The pyrethrum shortage continues, but Drione is now available and in good supply
Research Triangle Park, N.C. – March 28, 2011 – Bayer Environmental Science has announced that Drione®, a desiccant dust combined with synergized pyrethrins, is now available and in good supply. A worldwide shortage of pyrethrum, a key ingredient in Drione, has had limited availability in recent years. Bayer, however, has been able to secure enough material to meet demand for the remainder of 2011.
Approved for use in residences, commercial food handling establishments, food plants and granaries, Drione provides fast control, excellent flushing action and remains effective for up to six months. Drione features synergized natural pyrethrins plus amorphous silica gel that erodes the insect cuticle, causing the pest to die from dehydration.
“We’re thrilled to announce that Drione is back,” says Gordon Morrison, market manager for Bayer Environmental Science. “It’s effective, fast-acting and has a broad label that includes mattress applications for control of bed bugs, as it is non-staining and relatively odorless.”
For more information on Drione, visit your local Bayer authorized distributor, contact your local Bayer field sales representative or call Bayer customer service at 1-800-331-2867. Always read and follow label instructions.
# # #
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments